Return to study ST003328 main page

Download data matrix(Increased Cholesterol Synthesis Drives Neurotoxicity in Patient Stem Cell-Derived Model of Multiple Sclerosis - cellular lipidomics Reversed phase NEGATIVE ION MODE)

Download data matrix(Increased Cholesterol Synthesis Drives Neurotoxicity in Patient Stem Cell-Derived Model of Multiple Sclerosis - cellular lipidomics Reversed phase POSITIVE ION MODE)

AnalysisSamplesFactorsUnits
Reversed phase NEGATIVE ION MODEAMC A SV P1Disease status:AMC | Treatment:SV | Sample source:induced neural stem cellpeak area
Reversed phase NEGATIVE ION MODEAMC A SV P2Disease status:AMC | Treatment:SV | Sample source:induced neural stem cellpeak area
Reversed phase NEGATIVE ION MODEAMC A SV P3Disease status:AMC | Treatment:SV | Sample source:induced neural stem cellpeak area
Reversed phase NEGATIVE ION MODEAMC B SV P1Disease status:AMC | Treatment:SV | Sample source:induced neural stem cellpeak area
Reversed phase NEGATIVE ION MODEAMC B SV P2Disease status:AMC | Treatment:SV | Sample source:induced neural stem cellpeak area
Reversed phase NEGATIVE ION MODEAMC B SV P3Disease status:AMC | Treatment:SV | Sample source:induced neural stem cellpeak area
Reversed phase NEGATIVE ION MODEAMC C SV P1Disease status:AMC | Treatment:SV | Sample source:induced neural stem cellpeak area
Reversed phase NEGATIVE ION MODEAMC C SV P2Disease status:AMC | Treatment:SV | Sample source:induced neural stem cellpeak area
Reversed phase NEGATIVE ION MODEAMC C SV P3Disease status:AMC | Treatment:SV | Sample source:induced neural stem cellpeak area
Reversed phase NEGATIVE ION MODEAMC A P1Disease status:AMC | Treatment:untreated | Sample source:induced neural stem cellpeak area
Reversed phase NEGATIVE ION MODEAMC A P2Disease status:AMC | Treatment:untreated | Sample source:induced neural stem cellpeak area
Reversed phase NEGATIVE ION MODEAMC A P3Disease status:AMC | Treatment:untreated | Sample source:induced neural stem cellpeak area
Reversed phase NEGATIVE ION MODEAMC B P1Disease status:AMC | Treatment:untreated | Sample source:induced neural stem cellpeak area
Reversed phase NEGATIVE ION MODEAMC B P2Disease status:AMC | Treatment:untreated | Sample source:induced neural stem cellpeak area
Reversed phase NEGATIVE ION MODEAMC B P3Disease status:AMC | Treatment:untreated | Sample source:induced neural stem cellpeak area
Reversed phase NEGATIVE ION MODEAMC C P1Disease status:AMC | Treatment:untreated | Sample source:induced neural stem cellpeak area
Reversed phase NEGATIVE ION MODEAMC C P2Disease status:AMC | Treatment:untreated | Sample source:induced neural stem cellpeak area
Reversed phase NEGATIVE ION MODEAMC C P3Disease status:AMC | Treatment:untreated | Sample source:induced neural stem cellpeak area
Reversed phase NEGATIVE ION MODEPMA A SV P1Disease status:PMS | Treatment:SV | Sample source:induced neural stem cellpeak area
Reversed phase NEGATIVE ION MODEPMA A SV P2Disease status:PMS | Treatment:SV | Sample source:induced neural stem cellpeak area
Reversed phase NEGATIVE ION MODEPMA A SV P3Disease status:PMS | Treatment:SV | Sample source:induced neural stem cellpeak area
Reversed phase NEGATIVE ION MODEPMA B SV P1Disease status:PMS | Treatment:SV | Sample source:induced neural stem cellpeak area
Reversed phase NEGATIVE ION MODEPMA B SV P2Disease status:PMS | Treatment:SV | Sample source:induced neural stem cellpeak area
Reversed phase NEGATIVE ION MODEPMA B SV P3Disease status:PMS | Treatment:SV | Sample source:induced neural stem cellpeak area
Reversed phase NEGATIVE ION MODEPMS C SV P1Disease status:PMS | Treatment:SV | Sample source:induced neural stem cellpeak area
Reversed phase NEGATIVE ION MODEPMS C SV P2Disease status:PMS | Treatment:SV | Sample source:induced neural stem cellpeak area
Reversed phase NEGATIVE ION MODEPMS C SV P3Disease status:PMS | Treatment:SV | Sample source:induced neural stem cellpeak area
Reversed phase NEGATIVE ION MODEPMS D SV P1Disease status:PMS | Treatment:SV | Sample source:induced neural stem cellpeak area
Reversed phase NEGATIVE ION MODEPMS D SV P2Disease status:PMS | Treatment:SV | Sample source:induced neural stem cellpeak area
Reversed phase NEGATIVE ION MODEPMS D SV P3Disease status:PMS | Treatment:SV | Sample source:induced neural stem cellpeak area
Reversed phase NEGATIVE ION MODEPMA A P1Disease status:PMS | Treatment:untreated | Sample source:induced neural stem cellpeak area
Reversed phase NEGATIVE ION MODEPMA A P2Disease status:PMS | Treatment:untreated | Sample source:induced neural stem cellpeak area
Reversed phase NEGATIVE ION MODEPMA A P3Disease status:PMS | Treatment:untreated | Sample source:induced neural stem cellpeak area
Reversed phase NEGATIVE ION MODEPMA B P1Disease status:PMS | Treatment:untreated | Sample source:induced neural stem cellpeak area
Reversed phase NEGATIVE ION MODEPMA B P2Disease status:PMS | Treatment:untreated | Sample source:induced neural stem cellpeak area
Reversed phase NEGATIVE ION MODEPMA B P3Disease status:PMS | Treatment:untreated | Sample source:induced neural stem cellpeak area
Reversed phase NEGATIVE ION MODEPMS C P1Disease status:PMS | Treatment:untreated | Sample source:induced neural stem cellpeak area
Reversed phase NEGATIVE ION MODEPMS C P2Disease status:PMS | Treatment:untreated | Sample source:induced neural stem cellpeak area
Reversed phase NEGATIVE ION MODEPMS C P3Disease status:PMS | Treatment:untreated | Sample source:induced neural stem cellpeak area
Reversed phase NEGATIVE ION MODEPMS D P1Disease status:PMS | Treatment:untreated | Sample source:induced neural stem cellpeak area
Reversed phase NEGATIVE ION MODEPMS D P2Disease status:PMS | Treatment:untreated | Sample source:induced neural stem cellpeak area
Reversed phase NEGATIVE ION MODEPMS D P3Disease status:PMS | Treatment:untreated | Sample source:induced neural stem cellpeak area
Reversed phase POSITIVE ION MODEAMC A SV P1Disease status:AMC | Treatment:SV | Sample source:induced neural stem cellpeak area
Reversed phase POSITIVE ION MODEAMC A SV P2Disease status:AMC | Treatment:SV | Sample source:induced neural stem cellpeak area
Reversed phase POSITIVE ION MODEAMC A SV P3Disease status:AMC | Treatment:SV | Sample source:induced neural stem cellpeak area
Reversed phase POSITIVE ION MODEAMC B SV P1Disease status:AMC | Treatment:SV | Sample source:induced neural stem cellpeak area
Reversed phase POSITIVE ION MODEAMC B SV P2Disease status:AMC | Treatment:SV | Sample source:induced neural stem cellpeak area
Reversed phase POSITIVE ION MODEAMC B SV P3Disease status:AMC | Treatment:SV | Sample source:induced neural stem cellpeak area
Reversed phase POSITIVE ION MODEAMC C SV P1Disease status:AMC | Treatment:SV | Sample source:induced neural stem cellpeak area
Reversed phase POSITIVE ION MODEAMC C SV P2Disease status:AMC | Treatment:SV | Sample source:induced neural stem cellpeak area
Reversed phase POSITIVE ION MODEAMC C SV P3Disease status:AMC | Treatment:SV | Sample source:induced neural stem cellpeak area
Reversed phase POSITIVE ION MODEAMC A P1Disease status:AMC | Treatment:untreated | Sample source:induced neural stem cellpeak area
Reversed phase POSITIVE ION MODEAMC A P2Disease status:AMC | Treatment:untreated | Sample source:induced neural stem cellpeak area
Reversed phase POSITIVE ION MODEAMC A P3Disease status:AMC | Treatment:untreated | Sample source:induced neural stem cellpeak area
Reversed phase POSITIVE ION MODEAMC B P1Disease status:AMC | Treatment:untreated | Sample source:induced neural stem cellpeak area
Reversed phase POSITIVE ION MODEAMC B P2Disease status:AMC | Treatment:untreated | Sample source:induced neural stem cellpeak area
Reversed phase POSITIVE ION MODEAMC B P3Disease status:AMC | Treatment:untreated | Sample source:induced neural stem cellpeak area
Reversed phase POSITIVE ION MODEAMC C P1Disease status:AMC | Treatment:untreated | Sample source:induced neural stem cellpeak area
Reversed phase POSITIVE ION MODEAMC C P2Disease status:AMC | Treatment:untreated | Sample source:induced neural stem cellpeak area
Reversed phase POSITIVE ION MODEAMC C P3Disease status:AMC | Treatment:untreated | Sample source:induced neural stem cellpeak area
Reversed phase POSITIVE ION MODEPMA A SV P1Disease status:PMS | Treatment:SV | Sample source:induced neural stem cellpeak area
Reversed phase POSITIVE ION MODEPMA A SV P2Disease status:PMS | Treatment:SV | Sample source:induced neural stem cellpeak area
Reversed phase POSITIVE ION MODEPMA A SV P3Disease status:PMS | Treatment:SV | Sample source:induced neural stem cellpeak area
Reversed phase POSITIVE ION MODEPMA B SV P1Disease status:PMS | Treatment:SV | Sample source:induced neural stem cellpeak area
Reversed phase POSITIVE ION MODEPMA B SV P2Disease status:PMS | Treatment:SV | Sample source:induced neural stem cellpeak area
Reversed phase POSITIVE ION MODEPMA B SV P3Disease status:PMS | Treatment:SV | Sample source:induced neural stem cellpeak area
Reversed phase POSITIVE ION MODEPMS C SV P1Disease status:PMS | Treatment:SV | Sample source:induced neural stem cellpeak area
Reversed phase POSITIVE ION MODEPMS C SV P2Disease status:PMS | Treatment:SV | Sample source:induced neural stem cellpeak area
Reversed phase POSITIVE ION MODEPMS C SV P3Disease status:PMS | Treatment:SV | Sample source:induced neural stem cellpeak area
Reversed phase POSITIVE ION MODEPMS D SV P1Disease status:PMS | Treatment:SV | Sample source:induced neural stem cellpeak area
Reversed phase POSITIVE ION MODEPMS D SV P2Disease status:PMS | Treatment:SV | Sample source:induced neural stem cellpeak area
Reversed phase POSITIVE ION MODEPMS D SV P3Disease status:PMS | Treatment:SV | Sample source:induced neural stem cellpeak area
Reversed phase POSITIVE ION MODEPMA A P1Disease status:PMS | Treatment:untreated | Sample source:induced neural stem cellpeak area
Reversed phase POSITIVE ION MODEPMA A P2Disease status:PMS | Treatment:untreated | Sample source:induced neural stem cellpeak area
Reversed phase POSITIVE ION MODEPMA A P3Disease status:PMS | Treatment:untreated | Sample source:induced neural stem cellpeak area
Reversed phase POSITIVE ION MODEPMA B P1Disease status:PMS | Treatment:untreated | Sample source:induced neural stem cellpeak area
Reversed phase POSITIVE ION MODEPMA B P2Disease status:PMS | Treatment:untreated | Sample source:induced neural stem cellpeak area
Reversed phase POSITIVE ION MODEPMA B P3Disease status:PMS | Treatment:untreated | Sample source:induced neural stem cellpeak area
Reversed phase POSITIVE ION MODEPMS C P1Disease status:PMS | Treatment:untreated | Sample source:induced neural stem cellpeak area
Reversed phase POSITIVE ION MODEPMS C P2Disease status:PMS | Treatment:untreated | Sample source:induced neural stem cellpeak area
Reversed phase POSITIVE ION MODEPMS C P3Disease status:PMS | Treatment:untreated | Sample source:induced neural stem cellpeak area
Reversed phase POSITIVE ION MODEPMS D P1Disease status:PMS | Treatment:untreated | Sample source:induced neural stem cellpeak area
Reversed phase POSITIVE ION MODEPMS D P2Disease status:PMS | Treatment:untreated | Sample source:induced neural stem cellpeak area
Reversed phase POSITIVE ION MODEPMS D P3Disease status:PMS | Treatment:untreated | Sample source:induced neural stem cellpeak area
  logo